Wang Yuan-Chuen
Yuan-Chuen Wang, Department of Food Science and Biotechnology, National Chung Hsing University, Taichung 402, Taiwan.
World J Gastroenterol. 2014 Aug 14;20(30):10368-82. doi: 10.3748/wjg.v20.i30.10368.
More than 50% of the world population is infected with Helicobacter pylori (H. pylori). The bacterium highly links to peptic ulcer diseases and duodenal ulcer, which was classified as a group I carcinogen in 1994 by the WHO. The pathogenesis of H. pylori is contributed by its virulence factors including urease, flagella, vacuolating cytotoxin A (VacA), cytotoxin-associated gene antigen (Cag A), and others. Of those virulence factors, VacA and CagA play the key roles. Infection with H. pylori vacA-positive strains can lead to vacuolation and apoptosis, whereas infection with cagA-positive strains might result in severe gastric inflammation and gastric cancer. Numerous medicinal plants have been reported for their anti-H. pylori activity, and the relevant active compounds including polyphenols, flavonoids, quinones, coumarins, terpenoids, and alkaloids have been studied. The anti-H. pylori action mechanisms, including inhibition of enzymatic (urease, DNA gyrase, dihydrofolate reductase, N-acetyltransferase, and myeloperoxidase) and adhesive activities, high redox potential, and hydrophilic/hydrophobic natures of compounds, have also been discussed in detail. H. pylori-induced gastric inflammation may progress to superficial gastritis, atrophic gastritis, and finally gastric cancer. Many natural products have anti-H. pylori-induced inflammation activity and the relevant mechanisms include suppression of nuclear factor-κB and mitogen-activated protein kinase pathway activation and inhibition of oxidative stress. Anti-H. pylori induced gastric inflammatory effects of plant products, including quercetin, apigenin, carotenoids-rich algae, tea product, garlic extract, apple peel polyphenol, and finger-root extract, have been documented. In conclusion, many medicinal plant products possess anti-H. pylori activity as well as an anti-H. pylori-induced gastric inflammatory effect. Those plant products have showed great potential as pharmaceutical candidates for H. pylori eradication and H. pylori induced related gastric disease prevention.
World J Gastroenterol. 2014-8-14
Eksp Klin Gastroenterol. 2014
Arch Immunol Ther Exp (Warsz). 2009
J Korean Med Sci. 2012-1-27
Acta Pharm Sin B. 2025-8
World J Gastroenterol. 2025-5-28
Pol J Microbiol. 2025-3-26
Front Med (Lausanne). 2024-12-17
Front Pharmacol. 2024-11-19
Med Sci Monit. 2024-6-8
World J Clin Oncol. 2024-5-24
J Ethnopharmacol. 2013-3-7
Dig Dis Sci. 2013-2-20
Food Chem Toxicol. 2012-12-22
Front Cell Infect Microbiol. 2012-7-12
Front Cell Infect Microbiol. 2012-3-27